MarketPeel
Insider Trading Intelligence
Pricing
…
RD

Richard Daniell

TEVA
EVP, EUROPE COMMERCIAL · TEVA PHARMACEUTICAL INDUSTRIES LTD · CIK 0001726096
FILING MIX · LIFETIME38%/62%
BUYS
48
SELLS
77
TOTAL VALUE
$25.59M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
55,755
AVG SELL PX
$19.00
TRADE KIND
SHOWING 125 / 125
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
41 backtested trades · 8 horizons · 32 pending
Forward-return performance of every backtestable P/S trade by Richard Daniell, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d41+53.66%-1.28%-1.29%+0.01%-0.47%0.01
14d41+48.78%-1.56%-1.12%-0.35%+1.93%-0.28
30d41+60.98%-0.92%-1.99%+1.24%-0.13%0.70
60d41+26.83%+3.21%+1.38%+1.83%+3.81%1.00
90d41(1 pending)+25.00%+7.08%+3.66%+3.27%+6.04%0.97
180d41(6 pending)+31.43%+12.62%+10.12%+2.49%+4.99%0.68
1y41(7 pending)+20.59%+38.85%+17.32%+21.53%+8.48%2.60
2y41(18 pending)+30.43%+51.94%+31.20%+20.74%+12.87%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TEVA · 55,755 shares · as of May 5, 2026
062,251124,502186,752249,003202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 48 buys / 77 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Europe Commercial
30,000$35.40$1.06M55,755May 5, 2026May 7, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
17,295$31.67$547.7K85,755Mar 5, 2026Mar 9, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Europe Commercial
17,295——51,887Mar 5, 2026Mar 9, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Europe Commercial
17,295——103,050Mar 5, 2026Mar 9, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
20,461$32.46$664.3K123,127Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
33,512$32.46$1.09M123,127Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
37,372$32.95$1.23M85,755Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Europe Commercial
33,512——0Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Europe Commercial
33,512——156,639Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Europe Commercial
20,461——143,588Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Europe Commercial
20,461——40,923Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
33,424——33,424Mar 4, 2026Mar 6, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
66,735$32.36$2.16M123,127Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Europe Commercial
62,250——62,253Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
62,250$32.36$2.01M48,384Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Europe Commercial
62,250——110,634Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Europe Commercial
141,478——189,862Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Europe Commercial
141,478——0Mar 3, 2026Mar 5, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
141,478——141,478Jan 27, 2026Jan 29, 2026 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
115,468$28.68$3.31M48,384Dec 9, 2025Dec 11, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
15,011$16.99$255.0K163,852Dec 9, 2025Dec 11, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
100,457——0Dec 9, 2025Dec 11, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
15,011——0Dec 9, 2025Dec 11, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
100,457$18.61$1.87M148,841Dec 9, 2025Dec 11, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
11,641$15.91$185.2K0Mar 5, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
30,015$15.91$477.6K96,769Mar 5, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
7,108$15.91$113.1K0Mar 5, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
22,576$15.91$359.3K96,769Mar 5, 2025Mar 7, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
22,576——0Mar 5, 2025Mar 7, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
69,182——69,182Mar 5, 2025Mar 7, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
48,385$15.90$769.4K48,384Mar 5, 2025Mar 7, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
22,576——119,345Mar 5, 2025Mar 7, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
12,936$15.56$201.3K0Mar 4, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
183,169——0Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
20,461——20,461Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
21,870$15.73$344.1K11,641Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,461——61,384Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
183,169——183,169Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
56,385$15.73$887.2K126,784Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
13,353$15.73$210.1K7,108Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
33,512——33,512Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
33,512——33,512Mar 4, 2025Mar 6, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
62,250——124,503Mar 3, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
49,314$16.19$798.2K12,936Mar 3, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
62,250——62,250Mar 3, 2025Mar 5, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
183,169——183,169Jan 28, 2025Jan 30, 2025 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
98,943$17.30$1.71M0Aug 12, 2024Aug 13, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
22,576——22,576Mar 5, 2024Mar 7, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
22,576$13.52$305.1K69,770Mar 5, 2024Mar 7, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
22,576——92,346Mar 5, 2024Mar 7, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
55,226——0Mar 5, 2024Mar 7, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
55,226——124,996Mar 5, 2024Mar 7, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
26,053$13.52$352.1K98,943Mar 5, 2024Mar 7, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
33,512——67,024Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
33,512——103,282Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
33,512$13.34$447.0K69,770Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
81,845——81,845Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
62,250$13.34$830.2K69,770Mar 4, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
62,250——132,020Mar 3, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
62,250——186,753Mar 3, 2024Mar 5, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
20,599——90,369Feb 28, 2024Mar 1, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
20,599$13.12$270.2K69,770Feb 28, 2024Mar 1, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,599——0Feb 28, 2024Mar 1, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
55,226——55,226Jan 30, 2024Feb 1, 2024 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
54,007$9.43$509.2K69,770Mar 7, 2023Mar 8, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
18,002$9.93$178.8K123,777Mar 6, 2023Mar 8, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
22,576——141,779Mar 5, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
22,576——45,152Mar 5, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
33,512——119,203Mar 4, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
15,921——85,691Mar 4, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
33,512——100,536Mar 4, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
15,921——0Mar 4, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
249,003——249,003Mar 3, 2023Mar 7, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
50,242——93,424Feb 28, 2023Mar 2, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
20,598——63,780Feb 28, 2023Mar 2, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,598——20,599Feb 28, 2023Mar 2, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
23,654$9.89$233.9K69,770Feb 28, 2023Mar 2, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
50,242——0Feb 28, 2023Mar 2, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,598$9.89$203.6K43,182Feb 28, 2023Mar 2, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
50,242——50,242Feb 7, 2023Feb 9, 2023 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
22,576$7.37$166.3K43,182Mar 7, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
22,576——67,728Mar 5, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
22,576——65,758Mar 5, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
15,920$7.48$119.1K20,280Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
134,048——134,048Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
15,920——36,200Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
43,358——63,638Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
15,920——15,921Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
43,358——0Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,456$7.48$153.1K43,182Mar 4, 2022Mar 8, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
20,598——40,878Feb 28, 2022Mar 2, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,598$8.14$167.7K20,280Feb 28, 2022Mar 2, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,598——41,197Feb 28, 2022Mar 2, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
13,135——33,415Feb 9, 2022Feb 10, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
13,135$9.06$119.0K20,280Feb 9, 2022Feb 10, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
13,135——0Feb 9, 2022Feb 10, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
43,358——43,358Feb 8, 2022Feb 10, 2022 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
90,304——90,304Mar 5, 2021Mar 8, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
15,920——31,841Mar 4, 2021Mar 8, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
15,920——27,793Mar 4, 2021Mar 8, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
7,513$10.58$79.5K20,280Mar 4, 2021Mar 8, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
993$10.88$10.8K11,873Mar 3, 2021Mar 4, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
2,101——0Mar 3, 2021Mar 4, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
2,101——12,866Mar 3, 2021Mar 4, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,598$10.85$223.5K10,765Mar 1, 2021Mar 2, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
20,598——31,363Feb 28, 2021Mar 2, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
20,598——61,795Feb 28, 2021Mar 2, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
13,135$12.72$167.1K66,052Feb 9, 2021Feb 11, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
55,287$12.72$703.3K10,765Feb 9, 2021Feb 11, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
13,135——23,900Feb 9, 2021Feb 11, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
13,135——13,135Feb 9, 2021Feb 11, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
55,287——79,187Feb 9, 2021Feb 11, 2021 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
698——11,098Sep 9, 2020Sep 10, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
698——0Sep 9, 2020Sep 10, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
333$8.98$3.0K10,765Sep 9, 2020Sep 10, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
616$7.17$4.4K10,400Mar 17, 2020Mar 19, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
1,297——0Mar 17, 2020Mar 19, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
1,297——11,016Mar 17, 2020Mar 19, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
991$11.77$11.7K9,719Mar 3, 2020Mar 5, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
2,098——2,101Mar 3, 2020Mar 5, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
2,098——10,710Mar 3, 2020Mar 5, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
82,393——82,393Feb 28, 2020Mar 3, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
6,199$12.24$75.9K8,612Feb 10, 2020Feb 11, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Exec. VP, European Commercial
13,135——14,811Feb 9, 2020Feb 11, 2020 ↗View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Exec. VP, European Commercial
13,135——26,270Feb 9, 2020Feb 11, 2020 ↗View →
Other insiders · TEVA
Loading peer insiders…
About this filer
CIK 0001726096
ROLE
EVP, Europe Commercial
PRIMARY
TEVA
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001726096DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback